Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
abstract for parkinsons
abstract for parkinsons
parkinsons disease case study with medication
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: abstract for parkinsons
Introduction
Although Parkinson’s disease does not have a known cure, there are ways to treat and manage it. There are many components of treatments of Parkinson’s disease such as patient’s age, cognitive, life style, and symptom severity (Lyons & Pahwa, 2011, p. 29). With those components known, treatment can be modified based on the patient’s case. Treatment of Parkinson’s disease includes prescription drugs and non-pharmacologic treatment. One of the ways to manage Parkinson’s disease is prescription drugs. There are three common drugs that are used for management and treatment of Parkinson’s disease. The three frequent drugs that are used are Levodopa, Dopamine agonists and MAO-B inhibitor.
Levodopa
The first prescription drug is called Levodopa, according to the journal Clinical Medicine (2013) written by Worth mentions that “Levodopa in combination with the dopadeboxylase inhibitor benserazide (co-benelodopa) or carbidopa (co-caredopa) remains the most efficacious treatment for the motor symptoms of PD” (p. 93). Since Parkinson’s disease causes the loss of brain cells to produce dopamine. Dopamine is a chemical that is used for controlling movement. Without the production of dopamine in the brain, the patient has trouble with controlling their movement; their body may feel stiffness and tremors. Levodopa is used in early and advanced stages of Parkinson’s disease and it is used to help manage motor symptoms. Levodopa is a natural chemical that goes into the brain and is transformed into dopamine. This type of medication is used to treat tremors, spasms and poor muscle control of those who have Parkinson’s disease. Although Levodopa is used as a way to manage Parkinson’s disease, there are side effects to it as well. Some o...
... middle of paper ...
...or not if it’s possible to swallow and if not, there are alternative methods to feeding. The alternative methods can vary from a gastrointestinal tube and liquid diet. It’s different for every patient; their diet is modified based on the individual’s needs.
Conclusion
Prescription drugs and non-pharmacologic treatments have been proven to be effective up until 2013 when it comes to patients managing the symptoms of Parkinson’s disease. Depending on the patient and their symptom severity, prescription drugs and non-pharmacologic treatment can be adjusted accordingly. Although there is no known cure that will treat Parkinson’s disease, there are ways to manage it by using prescription drugs such as Levodopa, Dopamine Agonists and Mao-B inhibitor. Additional treatment can be sought by physical therapy, occupational therapy, and speech and swallowing therapy.
Parkinson’s disease is not a condition that is necessarily easy to be diagnosed. Therefore, the individual is advised to see a Parkinson’s specialist to receive the most accurate diagnosis and consider what the best course of treatment for the individual would be.
Many people, like myself, after watching an episode of “The Michael Jay Fox Show,” started to be come curious as to what exactly this disease is. You ask yourself; What is this disease? What causes it? Can it be passed down from generation to generation? Is there a treatment? What would your life be like suffering from this? Through my research on Parkinson’s disease, I am determined to answer these questions. I hope to have a better understanding on this disease, and how it affects the lives of patients that I might see in a hospital.
Varanese, S., Birnbaum, Z., Rossi, R., & Di Rocco, A. (2010). Treatment of Advanced Parkinson's Disease. Parkinson's Disease.
With more than 200,000 US cases per year, Parkinson’s disease has become a major part
Parkinson's disease is a neurological disorder that is named after "the English physician who first described it fully in 1817" (4). The disease causes disturbances in the motor functions resulting in patients having trouble moving. Other characteristics that are not always present in every patient are tremors and stiffening of limbs. All of these characteristics, of the disease are caused by "degeneration of a group of nerve cells deep within the center of the brain in an area called the substantia nigra" (5). Dopamine is the neurotransmitter for these cells to signal other nerve cells. However as the cluster of nerve cells fail to operate, the dopamine can not reach the areas of the brain that affects one's motor functions (5). On average Parkinson's patients have "less than half as much dopamine in their systems as healthy people do" (8). The problem and controversy that arises from this disease is in the cure. Researchers, for years, have been attempting to unravel the mystery of what causes Parkinson's disease and how it can be treated and or cur...
Parkinson disease (PD), also referred to as Parkinson’s disease and paralysis agitans, is a progressive neurodegenerative disease that is the third most common neurologic disorder of older adults. It is a debilitating disease affecting motor ability and is characterized by four cardinal symptoms: tremor rigidity, bradykinesia or kinesis (slow movement/no movement), and postural instability. Most people have primary, or idiopathic, disease. A few patients have secondary parkinsonian symptoms from conditions such as brain tumors and certain anti-psychotic drugs.
Paulson, G. W. Management of the patient with newly -diagnosed Parkinson’s disease. Geriatrics, Feb. 1993: 30-40.
Michael J Zigmond, Robert E. Burk, 1998. Pathophysiology of Parkinsons Disease. Neuropharmacology: the fifth Generation of progress.
Parkinson’s affects about one million people within the United States and about five million people worldwide. Most individuals who develop Parkinson 's disease are 60 years of age or older. Parkinson 's disease occurs in approximately 1% of individuals aged 60 years and in about 4% of those aged 80 years (Heyn and Stoppler, 2013). Since overall life expectancy is rising, the number of individuals with Parkinson 's disease will increase in the future. According to Sweeny (2013) Parkinson’s affects approximately 1.5% to 2.0% of people aged 60 years and older. Though it is rare, young adults may also be diagnosed with PD. Before the age of age if 21, the diagnosis is deemed juvenile onset. Between the ages of 21 to 40 it is called early onset. A significantly higher incidence rate of Parkinson’s disease was found among men with the relative risk being 1.5 times greater in men than women. (Wooten, Currie, Bovbjerg, Lee, and & Patrie,
Unfortunately, no treatment has been able to fully cure the disease. Treatment began primitively, consisting of things such as “bloodletting from the neck” which was followed by induced inflammation and blistering to the skin. Today, the most common and effective way of treating Parkinson’s temporarily is through attempting to balance dopamine and acetylcholine levels within the brain by prescribing patients with what is known on the market commonly as Levodopa. It is essentially a dopamine supplement of which’s dosage must be individualized for each different patient since the symptoms vary from person to person (Goldmann, 44). This treatment will eventually become less and less effective as the progression of the disease continues. All that patients and neurologists seem to be able to do is attempt to manage the symptoms it
"Secondary Parkinsonism: MedlinePlus Medical Encyclopedia." U.S National Library of Medicine. U.S. National Library of Medicine, n.d. Web. 11 May 2014.
There exists a group of people who live the final years of their lives in glass boxes. They are perfectly capable of seeing outside, but incapable of reaching out to the world around them. Their emotions can not be shown through facial expression, and as their condition continues, speech also becomes difficult or even impossible. These people are men and women of all races and geographical areas, constituting one percent of the world’s population over 50 years old. Parkinson disease is their affliction. Although Parkinsonism has been around almost as long as recorded history, there is yet to be found a cause or a cure. Medications tame the symptoms and prolong life, but are incapable of reversing the disease progression.. Diagnosis relies exclusively upon clinical signs and symptoms, because almost all laboratory and radiography tests are normal in the Parkinson patient. For this reason early diagnosis is very difficult. The fact that early signs of Parkinsonism can easily be overlooked as normal aging, further complicates diagnosis. Therefore, primary care physicians of the middle-aged and elderly population must be extremely sensitive to patients’ outward appearance and changes in movement ability.
Parkinson's Disease is a perpetual, dynamic, neurodegenerative sickness of the elderly for the most part influencing individuals at the age of 60. Nearly 5 million people are suffering from this disease all over the world and 1.2 million people are suffering in United States and Canada with approximately 480 per million people are newly diagnosed each year. This disease not only affects the patient but also it is a cause of worry among patient's loved ones and family members. Though, the news of the recent disease diagnosis haunt every individual and his nears and dears but due to several support groups and societies and several scientific breakthroughs have put a ray of hope in the life of individual living with Parkinson's disease.
Parkinson’s is considered to be chronic and progressive, meaning it is consistent and does not go away and will only increase intensity and severity of symptoms as the disease continues.
Parkinson’s disease, a chronic, progressive, and neurodegenerative brain disorder affecting body movement, known to have no cure, yet has treatments that will help in managing the disease. This disease is named after James Parkinson, an English physician who described this illness. Approximately one million people in the United States are diagnosed with Parkinson’s disease (What is Parkinson’s, n.d.). This disease is identified to be slow in progression and symptoms of this will only worsen as time goes on. Parkinson’s is the second most common neurodegenerative disease (Simpson, Murray, & Eccles, 2010).